Gastroenterology and Hepatology

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Barrett Esophagus 79%
3. Liver 76%
4. Irritable Bowel Syndrome 71%
5. Inflammatory Bowel Diseases 68%
6. Sclerosing Cholangitis 64%
7. Crohn Disease 63%
8. Celiac Disease 60%
9. Neoplasms 57%
10. Therapeutics 55%
11. Cholangiocarcinoma 51%
12. Fibrosis 49%
13. Liver Diseases 46%
14. Hepatocellular Carcinoma 43%
15. Colorectal Neoplasms 42%
16. Constipation 42%
17. Gastric Emptying 41%
18. Pancreatic Neoplasms 40%
19. Stomach 40%
20. Endoscopy 38%
21. Hepatocytes 37%
22. Adenocarcinoma 36%
23. Survival 32%
24. Bile Acids and Salts 32%
25. Non-alcoholic Fatty Liver Disease 31%
26. Biopsy 29%
27. Colon 29%
28. Gastrointestinal Diseases 29%
29. Biliary Liver Cirrhosis 29%
30. Diarrhea 29%
31. Gastroparesis 29%
32. Gastroesophageal Reflux 29%
33. Population 28%
34. Eosinophilic Esophagitis 27%
35. Confidence Intervals 27%
36. Apoptosis 27%
37. End Stage Liver Disease 25%
38. Placebos 25%
39. Pancreatitis 24%
40. Colonoscopy 24%
41. Systematic Reviews 24%
42. Autoimmune Pancreatitis 24%
43. Safety 23%
44. Bile Ducts 23%
45. Mortality 23%
46. Hemorrhage 23%
47. Genes 22%
48. Proteins 22%
49. Gastroenterology 22%
50. Incidence 21%
51. Obesity 20%
52. Inflammation 20%
53. Colonic Neoplasms 20%
54. Dyspepsia 20%
55. Recurrence 20%
56. Meta-Analysis 19%
57. Serum 19%
58. Biomarkers 19%
59. Manometry 18%
60. Portal Hypertension 18%
61. Infections 17%
62. Epidemiology 17%
63. Hepacivirus 17%
64. Pathologic Constriction 17%
65. Hepatitis C 17%
66. Esophagus 16%
67. Microbiota 16%
68. Dynamins 16%
69. Wounds and Injuries 16%
70. Glutens 16%
71. Elasticity Imaging Techniques 16%
72. Bile 16%
73. Transplant Recipients 15%
74. Chronic Pancreatitis 15%
75. Mutation 15%
76. Odds Ratio 15%
77. Liver Cirrhosis 15%
78. Microscopic Colitis 15%
79. Gastroenterologists 15%
80. Pharmaceutical Preparations 15%
81. Fecal Incontinence 15%
82. Pressure 14%
83. Gastrointestinal Microbiome 14%
84. Transplants 14%
85. Alcoholic Hepatitis 14%
86. Abdominal Pain 14%
87. Cohort Studies 14%
88. Colitis 14%
89. Phenotype 14%
90. Polyps 14%
91. Esophageal Neoplasms 14%
92. Stents 13%
93. Mucous Membrane 13%
94. Transplantation 13%
95. Hepatic Stellate Cells 13%
96. Gastrointestinal Transit 13%
97. Gastrointestinal Motility 13%
98. vedolizumab 13%
99. Endoscopic Retrograde Cholangiopancreatography 13%